Sarah J. Chalmers, M.D.

  1. Critical Care Specialist
  2. Internist
  3. Pediatrician
  4. Pulmonologist
  1. Aksamit TR, Locantore N, Addrizzo-Harris D, Ali J, Barker A, Basavaraj A, Behrman M, Brunton AE, Chalmers S, Choate R, Dean NC, DiMango A, Fraulino D, Johnson MM, Lapinel NC, Maselli DJ, McShane PJ, Metersky ML, Miller BE, Naureckas ET, O'Donnell AE, Olivier KN, Prusinowski E, Restrepo MI, Richards CJ, Rhyne G, Schmid A, Solomon GM, Tal-Singer R, Thomashow B, Tino G, Tsui K, Varghese SA, Warren HE, Winthrop K, Zha BS. Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients. Am J Respir Crit Care Med. 2024 Jul 1; 210 (1):108-118
    View PubMed
  2. Aksamit TR, Locantore N, Addrizzo-Harris D, Ali J, Barker A, Basavaraj A, Behrman M, Brunton AE, Chalmers S, Choate R, Dean NC, DiMango A, Fraulino D, Johnson MM, Lapinel NC, Maselli DJ, McShane PJ, Metersky ML, Miller BE, Naureckas ET, O'Donnell AE, Olivier KN, Prusinowski E, Restrepo MI, Richards CJ, Rhyne G, Schmid A, Solomon GM, Tal-Singer R, Thomashow B, Tino G, Tsui K, Varghese SA, Warren HE, Winthrop K, Zha BS. Five-year outcomes among U.S. bronchiectasis and NTM research registry patients. American Journal of Respiratory and Critical Care Medicine. 2024; 210 (1):108-18
  3. Peters BJ, Brown AE, Thornton NM, Winters JL, Chalmers SJ. The effect of plasma exchange on serum levels of lacosamide: A case report. Am J Health Syst Pharm. 2023 Dec 5; 80 (24):1781-1786
    View PubMed
  4. Arslan M, Bahadir Z, Basiaga ML, Chalmers SJ, Demirel N. A pediatric cystic fibrosis arthropathy case who responded to Elexacaftor/Tezacaftor/Ivacaftor therapy. J Cyst Fibros. 2023 Nov; 22 (6):1120-1122 Epub 2023 Sept 13
    View PubMed
  5. Stultz BR, Ewy MW, Chalmers SJ. 53-Year-Old Man With Dyspnea. Mayo Clin Proc. 2023 Nov; 98 (11):1697-1701
    View PubMed
  6. Arslan M, Chalmers S, Rentfrow K, Olson JM, Dean V, Wylam ME, Demirel N. Suicide attempts in adolescents with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor therapy. J Cyst Fibros. 2023 May; 22 (3):427-430 Epub 2023 Feb 08
    View PubMed
  7. Lal A, Mukhtar O, Chalmers SJ, Karp J, Wieruszewski PM, Park JG. Anticoagulation Prescribing Patterns in Intensive Care Unit Patients Admitted with Prehospital Direct Oral Anticoagulant Therapy: A Single Academic Center Experience. Hosp Pharm. 2023 Feb; 58 (1):84-91 Epub 2022 Sept 04
    View PubMed
  8. Li H, Bihari S, Weister T, LeMahieu A, Kashyap R, Chalmers S, Lal A, Bersten A, Gajic O. Admission serum sodium and osmolarity are not associated with the occurrence or outcomes of acute respiratory distress syndrome in critically ill. J Crit Care. 2023 Feb; 73:154179 Epub 2022 Oct 28
    View PubMed
  9. Chalmers SJ, Aksamit TR. New therapies for nontuberculous mycobacterial lung infection. Curr Opin Infect Dis. 2022 Apr 1; 35 (2):176-184
    View PubMed
  10. Odeyemi YE, Chalmers SJ, Barreto EF, Jentzer JC, Gajic O, Yadav H. Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial. Crit Care. 2022 Jan 4; 26 (1):9 Epub 2022 Jan 04
    View PubMed
  11. Chalmers SJ, Lal A, Gajic O, Kashyap R. Timing of ARDS Resolution (TARU): A Pragmatic Clinical Assessment of ARDS Resolution in the ICU. Lung. 2021 Oct; 199 (5):439-445 Epub 2021 Sept 29
    View PubMed
  12. Chalmers SJ, Odeyemi YE, Lal A, Li H, Frank RD, Gajic O, Yadav H. F(IO(2)) Trajectory as a Pragmatic Intermediate Marker in Acute Hypoxic Respiratory Failure. Respir Care. 2021 Oct; 66 (10):1521-1530 Epub 2021 Aug 17
    View PubMed
  13. Li H, Odeyemi YE, Weister TJ, Liu C, Chalmers SJ, Lal A, Song X, Gajic O, Kashyap R. Rule-Based Cohort Definitions for Acute Respiratory Distress Syndrome: A Computable Phenotyping Strategy Based on the Berlin Definition. Crit Care Explor. 2021 Jun; 3 (6):e0451 Epub 2021 June 11
    View PubMed
  14. Odeyemi YE, Herasevich S, Chalmers SJ, Barreto EF, Frank RD, Gajic OO, Yadav H. Biomarker-Concordant Steroid Use in Critically Ill Patients with Pneumonia. Mayo Clin Proc Innov Qual Outcomes. 2020 Dec; 4 (6):649-656 Epub 2020 Dec 10
    View PubMed
  15. Lal A, Li G, Cubro E, Chalmers S, Li H, Herasevich V, Dong Y, Pickering BW, Kilickaya O, Gajic O. Development and Verification of a Digital Twin Patient Model to Predict Specific Treatment Response During the First 24 Hours of Sepsis. Crit Care Explor. 2020 Nov; 2 (11):e0249 Epub 2020 Nov 16
    View PubMed
  16. Chalmers SJ, Murphy SJ, Thompson LL, Hoppman NL, Smadbeck JB, Balcom JR, Harris FR, Frantz RP, Vasmatzis G, E Wylam M. Mate-pair sequencing identifies a cryptic BMPR2 mutation in hereditary pulmonary arterial hypertension. Pulm Circ. 2020 Jul-Sep; 10 (3):2045894020933081 Epub 2021 July 12
    View PubMed
  17. Chalmers SJ, Wylam ME. Methicillin-Resistant Staphylococcus aureus Infection and Treatment Options. Methods Mol Biol. 2020; 2069:229-251
    View PubMed
  18. Fonseca Fuentes X, Kashyap R, Hays JT, Chalmers S, Lama von Buchwald C, Gajic O, Gallo de Moraes A. VpALI-Vaping-related Acute Lung Injury: A New Killer Around the Block. Mayo Clin Proc. 2019 Dec; 94 (12):2534-2545 Epub 2019 Nov 22
    View PubMed
  19. Chalmers S, Khawaja A, Wieruszewski PM, Gajic O, Odeyemi Y. Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: The role of inflammatory biomarkers. World J Crit Care Med. 2019 Sep 11; 8 (5):59-71 Epub 2019 Sept 11
    View PubMed
  20. Mersereau EJ, Boyle CA, Poitra S, Espinoza A, Seiler J, Longie R, Delvo L, Szarkowski M, Maliske J, Chalmers S, Darland DC, Darland T. Longitudinal Effects of Embryonic Exposure to Cocaine on Morphology, Cardiovascular Physiology, and Behavior in Zebrafish. Int J Mol Sci. 2016 May 31; 17 (6)
    View PubMed
  21. Chalmers S, Tarantino MD. Romiplostim as a treatment for immune thrombocytopenia: a review. J Blood Med. 2015; 6:37-44 Epub 2015 Jan 19
    View PubMed